Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study - Sekulic, A; Migden, M R; Basset-Seguin, N (BMC Cancer, 2017)
, et al; ERIVANCE BCC Investigators.